Incontinence Device Draft Guidance Suggests One-Year Randomized Studies
This article was originally published in The Gray Sheet
Executive Summary
Randomized, controlled trials are the least burdensome means of collecting data to demonstrate safety and effectiveness of urinary incontinence devices, according to a Sept. 19 FDA 1draft guidance